+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pulmonary Drug Delivery Devices Market by Device Type (Dry Powder Inhaler, Metered Dose Inhaler, Nasal Spray), Therapy (Allergic Rhinitis, Asthma, Bronchiectasis), Drug Type, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Pulmonary Drug Delivery Devices Market by Device Type (Dry Powder Inhaler, Metered Dose Inhaler, Nasal Spray), Therapy (Allergic Rhinitis, Asthma, Bronchiectasis), Drug Type, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Pulmonary Drug Delivery Devices Market by Device Type (Dry Powder Inhaler, Metered Dose Inhaler, Nasal Spray), Therapy (Allergic Rhinitis, Asthma, Bronchiectasis), Drug Type, End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968897
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The pulmonary drug delivery devices market is rapidly evolving, driven by advancements in inhaler design, shifting regulatory requirements, and increasing demand for patient-centric respiratory solutions. Senior decision-makers in healthcare and life sciences must navigate an increasingly complex environment as new technologies reshape disease management and supply chains require greater resilience.

Market Snapshot: Pulmonary Drug Delivery Devices Market Overview

The Pulmonary Drug Delivery Devices Market grew from USD 52.99 billion in 2024 to USD 56.19 billion in 2025. It is expected to continue expanding at a CAGR of 5.94%, ultimately reaching USD 74.93 billion by 2030. Strong drivers include the rising prevalence of respiratory diseases and technology adoption across established and emerging economies. Sophisticated delivery devices, evolving patient needs, and developments in both regulatory guidance and digital integration fuel this market’s momentum.

Scope & Segmentation

This comprehensive analysis covers the breadth and depth of the industry, providing segmented insight into device categories, therapeutic applications, drug classes, end users, routes to market, regional shifts, and leading manufacturer strategies.

  • Device Types: Dry powder inhalers, metered dose inhalers (CFC and HFA propellants), nasal sprays (propellant and pump actuator), mesh, jet and ultrasonic nebulizers, and soft mist inhalers.
  • Therapy Areas: Allergic rhinitis, asthma, bronchiectasis, chronic obstructive pulmonary disease, cystic fibrosis, and pulmonary arterial hypertension.
  • Drug Modalities: Biologics (monoclonal antibody, peptide, recombinant proteins), combination therapies (dual, triple, quad), small molecules, live attenuated and inactivated vaccines.
  • End Users: Clinics (general, respiratory), home healthcare, hospitals, and specialty centers.
  • Distribution Channels: Hospital and retail pharmacies, OTC and prescription e-commerce pharmacies.
  • Regional Markets: Americas (U.S., Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including UK, Germany, France, and others), Asia-Pacific (China, India, Japan, Australia, more).
  • Key Players: GlaxoSmithKline plc, AstraZeneca plc, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Novartis AG, Viatris Inc., Koninklijke Philips N.V., Becton, Dickinson and Company, 3M Company, AptarGroup, Inc.

Key Takeaways for Senior Decision-Makers

  • Emerging inhalation technologies and the rise of digital connectivity are enabling more personalized and data-driven respiratory treatment solutions.
  • Regulatory trends prioritize safety, eco-friendly materials, patient usability, and integration with adherence-monitoring platforms, reshaping product development pipelines.
  • Cost pressures and evolving reimbursement structures are influencing strategic alliances, with organizations pivoting toward regional supply chains and collaborative manufacturing models.
  • Therapeutic innovation is expanding, with inhalable biologics and combination therapies gaining traction, which may redefine standard-of-care and open new addressable patient segments.
  • Adoption patterns vary significantly by region due to disparities in regulatory speed, healthcare infrastructure, and digital health readiness.

Tariff Impact on the Pulmonary Drug Delivery Devices Market

US tariff changes in 2025 have significantly altered cost structures. Manufacturers relying on imported ingredients and specialist materials are contending with higher procurement expenses. In response, many are pursuing regional sourcing, domestic contract manufacturing, and more vertically integrated supply chains to minimize exposure and stabilize product pricing. These adjustments are also creating opportunities for supplier consolidation and collaborative logistics ventures as organizations seek to increase agility and resilience.

Methodology & Data Sources

This research utilizes both primary and secondary information for robust market analysis. Primary data includes direct interviews with industry executives, clinical specialists, stakeholders in procurement, and regulatory affairs. Secondary sources feature peer-reviewed literature, regulatory filings, patent reviews, and proprietary white papers. Cross-validation, triangulation, and normalization processes ensure precise data reconciliation and actionable insight development.

Why This Report Matters

  • Delivers actionable, segmented market intelligence for executive decision-making on investments, portfolio expansion, and supply chain strategies.
  • Clarifies regional differences and competitive landscapes, supporting targeted go-to-market planning and risk mitigation in high-variability environments.
  • Equips leaders to anticipate regulatory trends, drive technology adoption, and connect innovations directly to improved patient outcomes.

Conclusion: Strategic Insights for Market Leadership

The Pulmonary Drug Delivery Devices Market is adapting to changing global health drivers, collaborative innovation, and digital transformation. Leaders who leverage these insights will be best positioned to shape operational excellence and meet advancing patient and payer expectations in respiratory care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of digital inhaler sensors to monitor patient adherence and optimize dosing
5.2. Emergence of smart inhalers with Bluetooth connectivity for real time data analytics
5.3. Development of nanoparticle based aerosol formulations for targeted pulmonary drug delivery
5.4. Increasing adoption of dry powder inhalers with low environmental impact propellant alternatives
5.5. Advancements in mucosal vaccine delivery via inhalation for enhanced immune response
5.6. Integration of AI powered predictive algorithms in inhaler devices for early exacerbation detection
5.7. Expansion of companion diagnostics for personalized pulmonary therapy dosing strategies
5.8. Regulatory shifts promoting bioequivalence in generic inhaler approvals to enhance market competition
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Pulmonary Drug Delivery Devices Market, by Device Type
8.1. Introduction
8.2. Dry Powder Inhaler
8.2.1. Capsule Based
8.2.2. Multi Dose Reservoir
8.2.3. Single Dose Powder Reservoir
8.3. Metered Dose Inhaler
8.3.1. CFC Propellant
8.3.2. HFA Propellant
8.4. Nasal Spray
8.4.1. Propellant Based
8.4.2. Pump Actuator
8.5. Nebulizer
8.5.1. Jet Nebulizer
8.5.2. Mesh Nebulizer
8.5.3. Ultrasonic Nebulizer
8.6. Soft Mist Inhaler
9. Pulmonary Drug Delivery Devices Market, by Therapy
9.1. Introduction
9.2. Allergic Rhinitis
9.3. Asthma
9.4. Bronchiectasis
9.5. COPD
9.6. Cystic Fibrosis
9.7. Pulmonary Arterial Hypertension
10. Pulmonary Drug Delivery Devices Market, by Drug Type
10.1. Introduction
10.2. Biologics
10.2.1. Monoclonal Antibody
10.2.2. Peptide
10.2.3. Recombinant Proteins
10.3. Combination Therapy
10.3.1. Dual Combination
10.3.2. Quad Combination
10.3.3. Triple Combination
10.4. Small Molecule
10.5. Vaccines
10.5.1. Inactivated
10.5.2. Live Attenuated
11. Pulmonary Drug Delivery Devices Market, by End User
11.1. Introduction
11.2. Clinics
11.2.1. General Clinics
11.2.2. Respiratory Clinics
11.3. Home Healthcare
11.4. Hospitals
11.5. Specialty Centers
12. Pulmonary Drug Delivery Devices Market, by Distribution Channel
12.1. Introduction
12.2. Offline Pharmacies
12.2.1. Hospital Pharmacies
12.2.2. Retail Pharmacies
12.3. Online Pharmacies
12.3.1. OTC Ecommerce
12.3.2. Prescription Ecommerce
13. Americas Pulmonary Drug Delivery Devices Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Pulmonary Drug Delivery Devices Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Pulmonary Drug Delivery Devices Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. GlaxoSmithKline plc
16.3.2. AstraZeneca plc
16.3.3. Boehringer Ingelheim International GmbH
16.3.4. Teva Pharmaceutical Industries Ltd.
16.3.5. Novartis AG
16.3.6. Viatris Inc.
16.3.7. Koninklijke Philips N.V.
16.3.8. Becton, Dickinson and Company
16.3.9. 3M Company
16.3.10. AptarGroup, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. PULMONARY DRUG DELIVERY DEVICES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. PULMONARY DRUG DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. PULMONARY DRUG DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. PULMONARY DRUG DELIVERY DEVICES MARKET: RESEARCHAI
FIGURE 26. PULMONARY DRUG DELIVERY DEVICES MARKET: RESEARCHSTATISTICS
FIGURE 27. PULMONARY DRUG DELIVERY DEVICES MARKET: RESEARCHCONTACTS
FIGURE 28. PULMONARY DRUG DELIVERY DEVICES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PULMONARY DRUG DELIVERY DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CAPSULE BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CAPSULE BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY MULTI DOSE RESERVOIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY MULTI DOSE RESERVOIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY SINGLE DOSE POWDER RESERVOIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY SINGLE DOSE POWDER RESERVOIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CFC PROPELLANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CFC PROPELLANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HFA PROPELLANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HFA PROPELLANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PROPELLANT BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PROPELLANT BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PUMP ACTUATOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PUMP ACTUATOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY JET NEBULIZER, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY JET NEBULIZER, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY MESH NEBULIZER, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY MESH NEBULIZER, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZER, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZER, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY SOFT MIST INHALER, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY SOFT MIST INHALER, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ALLERGIC RHINITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ALLERGIC RHINITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ASTHMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ASTHMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BRONCHIECTASIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BRONCHIECTASIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COPD, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COPD, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PULMONARY ARTERIAL HYPERTENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PULMONARY ARTERIAL HYPERTENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PEPTIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PEPTIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DUAL COMBINATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DUAL COMBINATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY QUAD COMBINATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY QUAD COMBINATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY TRIPLE COMBINATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY TRIPLE COMBINATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY INACTIVATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RESPIRATORY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RESPIRATORY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OTC ECOMMERCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OTC ECOMMERCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRESCRIPTION ECOMMERCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRESCRIPTION ECOMMERCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 193. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 194. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 195. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2024 (USD MILLION)
TABLE 196. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2025-2030 (USD MILLION)
TABLE 197. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2024 (USD MILLION)
TABLE 198. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2025-2030 (USD MILLION)
TABLE 199. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2024 (USD MILLION)
TABLE 200. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2025-2030 (USD MILLION)
TABLE 201. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2024 (USD MILLION)
TABLE 202. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2025-2030 (USD MILLION)
TABLE 203. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 204. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 205. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 206. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 207. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 208. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 209. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 210. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 211. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 212. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 213. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 216. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 217. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 220. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 221. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 222. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 223. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 224. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 225. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2024 (USD MILLION)
TABLE 226. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2025-2030 (USD MILLION)
TABLE 227. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2024 (USD MILLION)
TABLE 228. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2025-2030 (USD MILLION)
TABLE 229. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2024 (USD MILLION)
TABLE 230. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2025-2030 (USD MILLION)
TABLE 231. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2024 (USD MILLION)
TABLE 232. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2025-2030 (USD MILLION)
TABLE 233. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 234. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 235. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 236. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 237. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 238. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 239. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 240. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 241. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 242. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 243. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 246. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 247. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 250. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 251. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 252. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SI

Samples

Loading
LOADING...

Companies Mentioned

  • GlaxoSmithKline plc
  • AstraZeneca plc
  • Boehringer Ingelheim International GmbH
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Viatris Inc.
  • Koninklijke Philips N.V.
  • Becton, Dickinson and Company
  • 3M Company
  • AptarGroup, Inc.

Table Information

Report AttributeDetails
No. of Pages190
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 56.19 Billion
Forecasted Market Value ( USD ) by 2030 $ 74.93 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Inhalation Pulmonary Drug Delivery Devices Market by Device Type (Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers), Drug Type (Antibiotics, Bronchodilators, Corticosteroids), End User Category, Distribution Channel - Global Forecast 2025-2030 - Product Image

Inhalation Pulmonary Drug Delivery Devices Market by Device Type (Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers), Drug Type (Antibiotics, Bronchodilators, Corticosteroids), End User Category, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Pulmonary Disease Aerosol Delivery Devices Market by Device Type (Dry Powder Inhalers, Nebulizers, Pressurized Metered Dose Inhalers), Product Type (Branded, Generic), Distribution Channel, End User, Portability - Global Forecast 2025-2030 - Product Image

Pulmonary Disease Aerosol Delivery Devices Market by Device Type (Dry Powder Inhalers, Nebulizers, Pressurized Metered Dose Inhalers), Product Type (Branded, Generic), Distribution Channel, End User, Portability - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Pulmonary / Respiratory Drug Delivery - Global Strategic Business Report - Product Image

Pulmonary / Respiratory Drug Delivery - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Pulmonary Drug Delivery Devices Market Report 2025 - Product Image

Pulmonary Drug Delivery Devices Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Aerosol Delivery Devices Market Report and Forecast 2025-2034 - Product Image

Aerosol Delivery Devices Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.